Pharmafile Logo
Pharmafocus logo
Advanced Search
screen_shot_2012-07-03_at_10

ICON announces senior clinical and laboratory appointments

July 3, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ICON

ICON, provider of outsourced development services to the pharma, biotech and medical device industries has announced appointments to the senior …

Appointment
rsa

RSA appoints new managing director for RSA Germany

July 3, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kristian Juergensen, appointment, recruitment firm, rsa

RSA, the life sciences recruitment specialist, has appointed Kristian Juergensen as its new managing director of RSA in Germany. Juergensen …

Appointment

China sets out quality rules for pharma excipients

July 3, 2012
Manufacturing and Production China, GMP, IPEC, manufacturing

China’s State Food & Drug Administration has published a draft regulation laying out a number of new measures for boosting …

News
Merck image

Merck closes Cherokee Pharma plant

July 3, 2012
Manufacturing and Production API, Cherokee Pharmaceuticals, Merck, manufacturing

Merck & Co has decided to close down part of a US plant operated by subsidiary Cherokee Pharmaceuticals after failing …

News

GSK to pay ‘unprecedented’ $3 billion fraud charge

July 3, 2012
Business Services, Sales and Marketing Avandia, Bextra, GSK, Paxil, Wellbutrin, Witty

GlaxoSmithKline will pay $3 billion in fraud charges, the largest of its kind in US history. The charges relate to …

News
screen_shot_2012-07-03_at_14

Strategic North makes two appointments

July 3, 2012
Business Services, Medical Communications, Sales and Marketing Strategic North

Healthcare strategic marketing agency Strategic North has expanded its team with the appointments of Sandra Du Cross in the role …

Appointment

FDA approves Astellas’ leaky bladder drug

July 3, 2012
Sales and Marketing Astellas, FDA, Myrbetriq, bladder, urology

The FDA has approved Astellas’ new overactive bladder disorder drug Myrbetriq.   Myrbetriq (mirabegron), the first drug in its class, works …

News
GSK image

GSK and Theravance post COPD pill data

July 2, 2012
Research and Development, Sales and Marketing COPD, GSK, LABA, LAMA, Theravance

GSK and partner Theravance have released new data for its combination COPD drug. Results from four late-stage trials suggest that …

News

Cmed Clinical Services launches new corporate brochure

July 2, 2012
Research and Development

Cmed Clinical Services is a long-established, flexible CRO with offices in the UK, US and Romania offering project management, clinical …

News
Press release
mark-porter-dr_2161169b

Doctors’ union the BMA appoints new chairman

July 2, 2012
Medical Communications, Research and Development, Sales and Marketing BMA, Dr Mark Porter, appointment

Dr Mark Porter, a consultant anaesthetist in Coventry, has been elected new chairman of the British Medical Association’s UK Council. …

Appointment
LaMattina image

John LaMattina: FDA tries to disavow role in higher hurdles for new drugs

July 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, Pfizer, US, discovery, drug

As evidenced by various blog posts that I have written over the past year (e.g., “Why Doesn’t the FDA Get …

Feature
EMA image

EMA publishes updated diabetes guidelines

July 2, 2012
Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda

The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …

News

Health Economics and Outcomes Research – What’s the Value?

July 2, 2012
Medical Communications HEOR, clinical evidence, economic evidence, market access, value

Pricing pressure and regulatory restrictions across various healthcare industries have called for more detailed evidence of outcomes

Feature
Thought Leadership
AZ image

AstraZeneca and BMS buy Amylin for $7 billion

July 2, 2012
Sales and Marketing Amylin, AstraZeneca, BMS

AstraZeneca and Bristol-Myers Squibb have struck a deal to purchase diabetes specialist Amylin in a complicated agreement worth $7 billion. …

News

Measuring Return on Investment of Health Economics and Outcomes Research through the Cloud

July 2, 2012
Medical Communications HEOR, ROI, interactive tools, market access

Health economics and outcomes research (HEOR) is a young and fascinating area of research with an engaged academic community. Methodology …

Feature
Thought Leadership
ariad_slideshow-3

Ariad touts next generation CML treatment

June 29, 2012
Research and Development, Sales and Marketing Ariad, CML, Cancer, Europe, Switzerland

Ariad Pharmaceuticals is to expand into Europe following promising results for an investigational cancer drug. The US biotech firm will …

News

McCann Torre Lazur wins Best of Health top prize

June 29, 2012
Medical Communications Best of Health awards, Euro RSCG Life UK, IPA, Langland, McCann Torre Lazur, Torre Lazur McCann, Woolley Pau

McCann Torre Lazur and The Cement Bloc were awarded the prestigious ‘Best of Show’ awards at the 2012 IPA Best …

News

Quintiles offers lifeline to Merck Serono employees

June 28, 2012
Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts, manufacturing

Quintiles has said it will make at least 100 job offers within the next three months to workers set to …

News

Albemarle expands API capacity at Michigan facility

June 28, 2012
Manufacturing and Production API, Albemarle, Michigan, manufacturing

Fine chemicals, polymers and catalysts specialist Albemarle has brought new manufacturing capacity for active pharmaceutical ingredients (APIs) online at its …

News

Growth in health spending ‘grinds to a halt’

June 28, 2012
Business Services, Sales and Marketing Financial, GDP, OECD, growth, pharma

Growth in health spending slowed or fell in real terms in 2010 in almost all OECD countries, reversing a long-term …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026